Literature DB >> 31425597

Chronic Systemic Symptoms in Head and Neck Cancer Patients.

Barbara A Murphy1, Elizabeth Wulff-Burchfield1, Michael Ghiam2, Stewart M Bond3, Jie Deng4.   

Abstract

The systemic effects and manifestations of disease and treatment have been of interest for millennium. Until recently, basic and clinical research is just now reaching a watershed. Systemic symptoms usually do not occur in isolation but rather in clusters; however, much of the cutting-edge research pertaining to the etiology, mechanism, manifestations, and moderators of systemic symptoms in humans has been directed at individual symptoms, thus creating silos of knowledge. Breaching these silos and bridging the knowledge from disparate arenas of investigation to build a comprehensive depiction of acute and chronic systemic symptoms has been a challenge. In addition, much of the recent work in systemic symptoms has been conducted in the setting of nonmalignant disease. The degree to which the findings from other chronic disease processes can be translated into the oncologic realm is unknown. This article will explore inflammation as a major contributing factor to systemic symptoms and sickness behavior, discuss the most common manifestations in cancer survivors, and, where available, discuss specific data pertaining to head and neck cancer survivors.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31425597     DOI: 10.1093/jncimonographs/lgz004

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  5 in total

1.  Assessing Physical and Cognitive Function in Individuals With Head and Neck Cancer: A Feasibility Study.

Authors:  Moira A Visovatti; Mi Sook Jung; Heidi Mason; Mary Beth DeRubeis; Francis P Worden; Debra L Barton
Journal:  Cancer Nurs       Date:  2022-01-12       Impact factor: 2.760

2.  Refinement and Validation of the Head and Neck Lymphedema and Fibrosis Symptom Inventory.

Authors:  Jie Deng; Mary S Dietrich; Kenneth J Niermann; Robert J Sinard; Anthony J Cmelak; Sheila H Ridner; Jill Gilbert; Barbara A Murphy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-10-14       Impact factor: 8.013

3.  Aromatic Sulfonamides including a Sulfonic Acid Tail: New Membrane Impermeant Carbonic Anhydrase Inhibitors for Targeting Selectively the Cancer-Associated Isoforms.

Authors:  Simone Giovannuzzi; Mario D'Ambrosio; Cristina Luceri; Sameh Mohamed Osman; Marco Pallecchi; Gianluca Bartolucci; Alessio Nocentini; Claudiu T Supuran
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 5.923

4.  Mechanisms of pain and their manifestations in head and neck cancer: Importance of classifying pain subtypes.

Authors:  Dianne I Lou; Mary S Dietrich; Jie Deng; Barbara A Murphy
Journal:  Head Neck       Date:  2021-10-07       Impact factor: 3.821

5.  Pretreatment Glasgow Prognostic Score Correlated with Serum Histidine Level and Three-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma and Optimal Performance Status.

Authors:  Kun-Yun Yeh; Chao-Hung Wang; Hang Huong Ling; Chia-Lin Peng; Zih-Syuan Chen; Simon Hsia
Journal:  Nutrients       Date:  2022-08-24       Impact factor: 6.706

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.